Merck
CN
Search Within

123-92-2

Applied Filters:
Keyword:'123-92-2'
Showing 1-16 of 16 results for "123-92-2" within Papers
Einat Peles et al.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 15(8), 620-628 (2014-03-29)
Methadone maintenance treatment (MMT) patients may achieve up to a 2-week privilege of methadone take-home doses (THD), which is associated with considerable responsibility. MMT patients are characterized as having poor sleep quality and low cognitive states. We studied sleep indices
Robertson D Davenport et al.
Transfusion, 44(6), 849-852 (2004-05-26)
Cefotetan can cause severe immune hemolytic anemia that may persist long after the drug is discontinued. To study the binding of cefotetan to RBCs, patients who received cefotetan were followed and tested for the presence of antibody to cefotetan. Patients
Brian H Kushner et al.
Cancer, 119(3), 665-671 (2012-09-07)
The authors report a retrospective analysis of high-dose ifosfamide, carboplatin, and etoposide (HD-ICE) for patients with refractory or relapsed neuroblastoma (NB). A major reason for using this regimen was the long time since patients received previous treatment with a platinum
Adarsh S Reddy et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 31(27), 9945-9957 (2011-07-08)
Globoid-cell leukodystrophy (GLD) is an inherited demyelinating disease caused by the deficiency of the lysosomal enzyme galactosylceramidase (GALC). A previous study in the murine model of GLD (twitcher) demonstrated a dramatic synergy between CNS-directed adeno-associated virus 2/5 (AAV2/5) gene therapy
Munekage Yamaguchi et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 25(9), 1645-1651 (2015-10-27)
There has been no consensus on the indications for the treatment of advanced low-grade endometrial stromal sarcoma (LGESS), and the possible effects of hormonal treatment including progestins and aromatase inhibitors have been reported. The aim of this study was to
N Minematsu et al.
Thorax, 58(7), 623-628 (2003-07-02)
Nicotine is responsible for smoking dependence and is mainly metabolised by CYP2A6. Several types of genetic polymorphism of CYP2A6 have been reported, but their relation to smoking habit and chronic obstructive pulmonary disease (COPD) phenotypes has not been fully clarified.
Nagaraju Konda et al.
Optometry and vision science : official publication of the American Academy of Optometry, 91(1), 47-53 (2013-11-12)
To investigate the utility of additional microbial analyses to detect the causative microorganism of microbial keratitis and to determine the strength of association between clinical variables. This retrospective study included 125 eyes of 123 people presenting with presumed infectious keratitis
Tomás Zelinka et al.
Endocrine-related cancer, 15(1), 311-323 (2008-03-04)
We performed a retrospective analysis of 71 subjects with metastatic pheochromocytoma and paraganglioma (30 subjects with mutation of succinate dehydrogenase enzyme subunit B (SDHB) gene and 41 subjects without SDHB mutation). Sixty-nine percent presented with bone metastases (SDHB +/-: 77%
Catherine M Rondelli et al.
Toxicological sciences : an official journal of the Society of Toxicology, 115(1), 41-50 (2010-01-29)
The impact of single-nucleotide polymorphisms (SNPs) of the DNA repair gene XPC on DNA repair capacity (DRC) and genotoxicity has not been comprehensively determined. We constructed a comprehensive haplotype map encompassing all common XPC SNPs and evaluated the effect of
Marta Del Pino et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 28(2), 312-320 (2014-09-06)
Several high-risk human papillomavirus (HPV)-induced cell biomarkers have been proposed as possible candidates to identify patients harboring high-grade squamous intraepithelial lesions (HSILs) of the uterine cervix. We aimed to determine the feasibility of the detection of the mRNA of six
Jan P Baak et al.
Cancer, 103(11), 2304-2312 (2005-04-28)
The objective of this study was to compare the accuracy of disease progression prediction of the molecular genetics and morphometry-based Endometrial Intraepithelial Neoplasia (EIN) and World Health Organization 1994 (WHO94) classification systems in patients with endometrial hyperplasias. A multicenter, multivariate
Mark S Sulkowski et al.
The New England journal of medicine, 370(3), 211-221 (2014-01-17)
All-oral combination therapy is desirable for patients with chronic hepatitis C virus (HCV) infection. We evaluated daclatasvir (an HCV NS5A replication complex inhibitor) plus sofosbuvir (a nucleotide analogue HCV NS5B polymerase inhibitor) in patients infected with HCV genotype 1, 2
Paolo Ferrari et al.
Nephrology (Carlton, Vic.), 15(3), 344-349 (2010-05-18)
To assess whether pentoxifylline improves anaemia of chronic kidney disease (CKD) via suppression of interleukin-6 (IL-6) and improved iron mobilization. CKD patients may have elevated IL-6 and tumour necrosis factor alpha levels. These cytokines can increase hepcidin production, which in
Guruprasad Rao et al.
Molecular vision, 14, 666-674 (2008-04-11)
Our previous work identified 23 low molecular weight (<3.5 kDa) crystallin peptides in the urea-soluble fractions of normal young, normal aged, and aged cataract human lenses. We found that one of these crystallin fragments, betaA3/A1(102-117) peptide (SDAYHIERLMSFRPIC), that are present
Bhavan Prasad Rai et al.
The Cochrane database of systematic reviews, 4, CD011903-CD011903 (2019-04-25)
It has been suggested that in comparison with open radical cystectomy, robotic-assisted radical cystectomy results in less blood loss, shorter convalescence, and fewer complications with equivalent short-term oncological and functional outcomes; however, uncertainty remains as to the magnitude of these
Rebekah L Hanson et al.
Journal of managed care pharmacy : JMCP, 19(1), 49-67 (2013-02-07)
Tumor necrosis factor (TNF)-alpha inhibitors and other biologic response modifiers (BRMs) are frequently used to treat a variety of inflammatory diseases. Use of these agents may increase risk of serious infections, malignancies, and other complications such as worsening symptoms of
Page 1 of 1